Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
Chemed (NYSE: CHE) will release fourth-quarter 2025 financial results for the period ended December 31, 2025 on Wednesday, February 25, 2026 after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Chemed (NYSE: CHE) will release fourth-quarter 2025 financial results for the period ended December 31, 2025 on Wednesday, February 25, 2026 after market close. The company will host a conference call and webcast at 10:00 a.m. ET on Thursday, February 26, 2026 to discuss results and provide a business update.
Investors may access a live webcast via Chemed's Investor Relations website or the provided media-server link. Registration for teleconference dial-in is required and will provide a personalized conference code; callers are asked to dial in 15 minutes early. A taped replay will be available roughly two hours after the call via the investor relations webcast. Chemed operates two subsidiaries: VITAS Healthcare and Roto-Rooter.
Details
News Market Reaction – CHE
On Jan 2, the day this news came out, CHE closed 0.95% below the previous close.
Data tracked by StockTitan Argus for the Jan 2 session.
Historical Context
-
Announcement of BofA virtual home care conference presentation and webcast access.
-
VITAS hospice-care video release highlighting home hospice caregiver experience.
-
Declaration of $0.60 quarterly dividend, continuing a 218-quarter streak.
-
UBS Global Healthcare Conference appearance with live webcast and posted materials.
-
Q3 2025 results with revenue growth but lower GAAP and adjusted EPS year over year.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
webcast technical
forward-looking statements regulatory
hospice care medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange.
Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 26, 2026, to discuss the company's quarterly results and to provide an update on its business.
Participants may access a live webcast of the conference call through the investor relations section of Chemed’s website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/srzsz65g.
Participants may also register via teleconference at https://register-conf.media-server.com/register/BIe4160b0d86fb4a3cb11588d64e00d9e7.
Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call. All participants are instructed to dial-in 15 minutes prior to the start time.
A taped replay of the conference call will be available beginning approximately two hours after the call's conclusion. You may access the replay via webcast through the investor relations section of Chemed’s website.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
CONTACT:
Michael D. Witzeman
(513) 762-6714
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.